Combined with a Drosophila AD model expressing human Tau, this study associated the inhibition of METTL3, METTL14, or YTHDF with enhanced Tau toxicity, thus hinting at a potential role of m6A in the regulation of AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.